Supplementary Table.docx

<b>Supplementary Table 1. </b>Osteoporosis medication codes and diagnostic codes for fractures<b>Supplementary Table 2.</b> Baseline characteristics by presence or absence of hypoparathyroidism in thyroid cancer patients<b>Supplementary Table 3</b>. Risk of osteoporotic fracture and medication in thyroid cancer patients without hypoparathyroidism compared to matched controls.<b>Supplementary Table 4. </b>Risk of osteoporotic fractures based on levothyroxine dose, calcium, and vitamin D supplements in thyroid cancer patients with hypoparathyroidism.